166 related articles for article (PubMed ID: 10400673)
1. Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin.
Gigoux V; Escrieut C; Fehrentz JA; Poirot S; Maigret B; Moroder L; Gully D; Martinez J; Vaysse N; Fourmy D
J Biol Chem; 1999 Jul; 274(29):20457-64. PubMed ID: 10400673
[TBL] [Abstract][Full Text] [Related]
2. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
Gigoux V; Maigret B; Escrieut C; Silvente-Poirot S; Bouisson M; Fehrentz JA; Moroder L; Gully D; Martinez J; Vaysse N; Fourmy AD
Protein Sci; 1999 Nov; 8(11):2347-54. PubMed ID: 10595537
[TBL] [Abstract][Full Text] [Related]
3. The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor. Evidence for a crucial role of Met-121 in the activation process.
Escrieut C; Gigoux V; Archer E; Verrier S; Maigret B; Behrendt R; Moroder L; Bignon E; Silvente-Poirot S; Pradayrol L; Fourmy D
J Biol Chem; 2002 Mar; 277(9):7546-55. PubMed ID: 11724786
[TBL] [Abstract][Full Text] [Related]
4. Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin.
Kennedy K; Gigoux V; Escrieut C; Maigret B; Martinez J; Moroder L; Fréhel D; Gully D; Vaysse N; Fourmy D
J Biol Chem; 1997 Jan; 272(5):2920-6. PubMed ID: 9006937
[TBL] [Abstract][Full Text] [Related]
5. Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies.
Galés C; Poirot M; Taillefer J; Maigret B; Martinez J; Moroder L; Escrieut C; Pradayrol L; Fourmy D; Silvente-Poirot S
Mol Pharmacol; 2003 May; 63(5):973-82. PubMed ID: 12695525
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a direct interaction between the penultimate aspartic acid of cholecystokinin and histidine 207, located in the second extracellular loop of the cholecystokinin B receptor.
Silvente-Poirot S; Escrieut C; Galès C; Fehrentz JA; Escherich A; Wank SA; Martinez J; Moroder L; Maigret B; Bouisson M; Vaysse N; Fourmy D
J Biol Chem; 1999 Aug; 274(33):23191-7. PubMed ID: 10438490
[TBL] [Abstract][Full Text] [Related]
7. Mutation of Asn-391 within the conserved NPXXY motif of the cholecystokinin B receptor abolishes Gq protein activation without affecting its association with the receptor.
Galés C; Kowalski-Chauvel A; Dufour MN; Seva C; Moroder L; Pradayrol L; Vaysse N; Fourmy D; Silvente-Poirot S
J Biol Chem; 2000 Jun; 275(23):17321-7. PubMed ID: 10748160
[TBL] [Abstract][Full Text] [Related]
8. Met-195 of the cholecystokinin-A receptor interacts with the sulfated tyrosine of cholecystokinin and is crucial for receptor transition to high affinity state.
Gigoux V; Escrieut C; Silvente-Poirot S; Maigret B; Gouilleux L; Fehrentz JA; Gully D; Moroder L; Vaysse N; Fourmy D
J Biol Chem; 1998 Jun; 273(23):14380-6. PubMed ID: 9603948
[TBL] [Abstract][Full Text] [Related]
9. Single amino acid substitution of serine82 to asparagine in first intracellular loop of human cholecystokinin (CCK)-B receptor confers full cyclic AMP responses to CCK and gastrin.
Wu SV; Yang M; Avedian D; Birnbaumer M; Walsh JH
Mol Pharmacol; 1999 May; 55(5):795-803. PubMed ID: 10220557
[TBL] [Abstract][Full Text] [Related]
10. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
[TBL] [Abstract][Full Text] [Related]
11. Basic amino acids at the C-terminus of the third intracellular loop are required for the activation of phospholipase C by cholecystokinin-B receptors.
Wang HL
J Neurochem; 1997 Apr; 68(4):1728-35. PubMed ID: 9084447
[TBL] [Abstract][Full Text] [Related]
12. Refinement of the conformation of a critical region of charge-charge interaction between cholecystokinin and its receptor.
Ding XQ; Pinon DI; Furse KE; Lybrand TP; Miller LJ
Mol Pharmacol; 2002 May; 61(5):1041-52. PubMed ID: 11961122
[TBL] [Abstract][Full Text] [Related]
13. The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK(1) receptor.
Gouldson P; Legoux P; Carillon C; Delpech B; Le Fur G; Ferrara P; Shire D
Eur J Pharmacol; 2000 Jul; 400(2-3):185-94. PubMed ID: 10988332
[TBL] [Abstract][Full Text] [Related]
14. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
Silvente Poirot S; Hadjiivanova C; Escrieut C; Dufresne M; Martinez J; Vaysse N; Fourmy D
Eur J Biochem; 1993 Mar; 212(2):529-38. PubMed ID: 8444190
[TBL] [Abstract][Full Text] [Related]
15. Conformational and molecular modeling studies of sulfated cholecystokinin-15.
Giragossian C; Stone S; Papini AM; Moroder L; Mierke DF
Biochem Biophys Res Commun; 2002 May; 293(3):1053-9. PubMed ID: 12051766
[TBL] [Abstract][Full Text] [Related]
16. First intracellular loop of the human cholecystokinin-A receptor is essential for cyclic AMP signaling in transfected HEK-293 cells.
Wu V; Yang M; McRoberts JA; Ren J; Seensalu R; Zeng N; Dagrag M; Birnbaumer M; Walsh JH
J Biol Chem; 1997 Apr; 272(14):9037-42. PubMed ID: 9083028
[TBL] [Abstract][Full Text] [Related]
17. Key differences in molecular complexes of the cholecystokinin receptor with structurally related peptide agonist, partial agonist, and antagonist.
Arlander SJ; Dong M; Ding XQ; Pinon DI; Miller LJ
Mol Pharmacol; 2004 Sep; 66(3):545-52. PubMed ID: 15322246
[TBL] [Abstract][Full Text] [Related]
18. The cholecystokinin analogues JMV-180 and CCK-8 stimulate phospholipase C through the same binding site of CCK(A) receptor in rat pancreatic acini.
Sarri E; Ramos B; Salido GM; Claro E
Br J Pharmacol; 2001 Aug; 133(8):1227-34. PubMed ID: 11498507
[TBL] [Abstract][Full Text] [Related]
19. Modeled structure of a G-protein-coupled receptor: the cholecystokinin-1 receptor.
Archer-Lahlou E; Tikhonova I; Escrieut C; Dufresne M; Seva C; Pradayrol L; Moroder L; Maigret B; Fourmy D
J Med Chem; 2005 Jan; 48(1):180-91. PubMed ID: 15634012
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism underlying partial and full agonism mediated by the human cholecystokinin-1 receptor.
Archer-Lahlou E; Escrieut C; Clerc P; Martinez J; Moroder L; Logsdon C; Kopin A; Seva C; Dufresne M; Pradayrol L; Maigret B; Fourmy D
J Biol Chem; 2005 Mar; 280(11):10664-74. PubMed ID: 15632187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
